Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1/1b Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05172245
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:09.446222+00:00
Published At
2026-04-17T00:00:00+00:00
Record Updated At
2026-04-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Head and Neck Carcinoma of Unknown Primary", "Locally Advanced Head and Neck Squamous Cell Carcinoma", "Locally Advanced Hypopharyngeal Squamous Cell Carcinoma", "Locally Advanced Laryngeal Squamous Cell Carcinoma", "Locally Advanced Nasal Cavity Squamous Cell Carcinoma", "Locally Advanced Oral Cavity Squamous Cell Carcinoma", "Locally Advanced Oropharyngeal Squamous Cell Carcinoma", "Locally Advanced Paranasal Sinus Squamous Cell Carcinoma", "Locally Advanced Sinonasal Squamous Cell Carcinoma", "Maxillary Sinus Squamous Cell Carcinoma", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage III Sinonasal Cancer AJCC v8", "Stage IVA Hypopharyngeal Carcinoma AJCC v8", "Stage IVA Laryngeal Cancer AJCC v8", "Stage IVA Lip and Oral Cavity Cancer AJCC v8", "Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVA Sinonasal Cancer AJCC v8", "Stage IVB Hypopharyngeal Carcinoma AJCC v8", "Stage IVB Laryngeal Cancer AJCC v8", "Stage IVB Lip and Oral Cavity Cancer AJCC v8", "Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVB Sinonasal Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-17"
protocolSection.identificationModule.nctId
"NCT05172245"
protocolSection.identificationModule.officialTitle
"Phase 1/1b Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Head and Neck Carcinoma of Unknown Primary (protocolSection.conditionsModule.conditions)
  • Locally Advanced Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Hypopharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Laryngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Nasal Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Paranasal Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced Sinonasal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Maxillary Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Sinonasal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Sinonasal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Sinonasal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.